← Back to Search
Behavioral Intervention
Telemedicine for Post Intensive Care Syndrome (TelePORT Trial)
Nashville, TN
N/A
Recruiting
Led By Leanne M Boehm, PhD
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial focuses on studying the long-term cognitive impairment in patients after they have been in intensive care. The study aims to understand how this impairment affects patients' ability to live independently, work, and manage
See full description
Who is the study for?
This trial is for adults over 45 who were in a medical or surgical ICU, treated for acute respiratory failure with mechanical ventilation and/or septic shock with vasopressors. It's not suitable for those who don't meet these specific conditions.
What is being tested?
The TelePORT Study is testing the use of telemedicine visits to help patients recover cognitive skills after intensive care. It aims to see if this can improve their ability to live independently and manage daily tasks.See study design
What are the potential side effects?
Since the intervention involves telehealth visits rather than medication, there are no direct physical side effects expected from participating in this study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Cognitive function - MoCA
Cognitive function - PROMIS
Secondary study objectives
Mental health - PTSD
Mental health - anxiety/depression
Physical function - ADL
+4 moreOther study objectives
Post-Traumatic Growth
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Telemedicine ICU Recovery ClinicExperimental Treatment1 Intervention
scheduled telemedicine study visits 3 weeks and 3 months after hospital discharge or return-to-home if discharged to another facility
Group II: Standard Recovery Conditions (i.e., Control)Active Control1 Intervention
Control group participants will proceed with follow-up as determined by the discharging hospital team and directed to use the provided PICS guide to connect with commonly used resources.
Find a Location
Closest Location:Vanderbilt University Medical Center· Nashville, TN
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,834 Previous Clinical Trials
28,184,348 Total Patients Enrolled
Vanderbilt UniversityLead Sponsor
713 Previous Clinical Trials
6,142,628 Total Patients Enrolled
Ohio State UniversityOTHER
878 Previous Clinical Trials
658,799 Total Patients Enrolled
Leanne M Boehm, PhDPrincipal InvestigatorVanderbilt University